ClinicalTrials.gg
Not yet recruitingNCT07931469REAL-DTTUpdated Nov 12, 2026

Real-life Dual-Task Training for Older Adults at Risk to Fall: A Pilot Clinical Trial

An interventional study of Real-life Dual-Task Training and Fall Prevention Education in Fall, sponsored by Colorado State University. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Colorado State University · Not applicable, Interventional, and Treatment

Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Older adults have difficulty optimizing two tasks at once and typically experience greater interference than younger adults when dual-tasking, meaning that there is greater decline in performance of at least one task when comparing single and dual-tasking. Difficulty dual-tasking may actually predict falls in community-dwelling older adults. Dual-task training has been shown to improve cognitive outcomes (attention, memory), motor outcomes (balance, gait), and dual-task performance in older adults; however, most dual-task training involves simulated tasks that do not reflect functional dual tasks in the real world. Greater dual-task improvements could be seen when training functionally specific tasks. One way to increase task specificity is to offer real-life, contextually-relevant, dual-task training embedded in instrumental activities of daily living (IADLs). Therefore, the purpose of this study is to assess feasibility, acceptability, and preliminary efficacy of a real-life dual-task training program for older adults at risk to fall compared to fall prevention education.

02

Conditions studied

  • Fall
03

In context

Lead sponsor

Colorado State University is the lead sponsor of 118 studies on the registry; 20 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥65 years old
  • fall risk identified from one of the Centers for Disease Control STEADI Three Key Questions Screen
  • ambulatory in the home with or without an assistive device
  • fluent in English

Exclusion criteria

Exclusion Criteria:

  • cognitive impairment as evidenced by Score screening
  • unstable cardiac condition (e.g., unstable angina, acute myocarditis, acute pericarditis)
  • acute systemic infection
  • active cancer treatment
  • prisoners
  • unable or unwilling to attend assessment or intervention sessions (Colorado State University)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Real-life Dual-Task Training

    Six real-life dual-task training sessions with explicit focus on motor and cognitive components of instrumental activities of daily living. Training occurs with a licensed occupational therapist, and activity selection and grading is guided by the therapist and participant.

    Behavioral: Real-life Dual-Task Training

  • Active comparator
    Fall Prevention Education

    Six guided fall prevention education sessions combining evidence-based fall prevention topics, CDC patient fall prevention handouts, NIH/NCOA fall prevention education resources, and tailored discussion utilizing behavior-change techniques.

    Behavioral: Fall Prevention Education

Interventions

  • BehavioralReal-life Dual-Task Training

    The intervention is Real-life Dual-Task Training (Real-DTT) which uses instrumental activities of daily living training with explicit focus on the cognitive and motor elements and progressive complexity. A structured debrief is used to determine when to focus attention on cognitive vs. motor tasks in order to reduce fall risk. The Real-DTT sessions will be delivered once a week for 6 weeks and delivered by a licensed occupational therapist. Real-DTT is a modified version of occupational therapy, with a protocol tailored to the participants.

  • BehavioralFall Prevention Education

    Guided fall prevention education combining evidence-based fall prevention topics, CDC patient fall prevention handouts, NIH/NCOA fall prevention education resources, and tailored discussion utilizing behavior-change techniques.

06

What researchers measure

Primary outcomes

  1. Cognitive Dual-Task Effect

    Cognitive Dual-task Effect is a percent change from single to dual-tasking: (\[dual-task-singletask\]/single-task) \*100. The cognitive condition is verbal fluency. The dual-task condition combines verbal fluency (cognitive) through the Timed Up \& Go dual task.

    Time frame: Baseline, week 6-7, week 12-14

  2. Motor Dual-Task Effect

    Motor Dual-task Effect is calculated as a motor percent changes from single to dual-tasking: (\[dual-task-singletask\]/single-task) \*100. The percent change calculates the difference in time in seconds to complete the Timed Up \& Go from single to dual-task.

    Time frame: Baseline, week 6-7, week 12-14

Secondary outcomes

  1. Performance-Based Assessment of Self-Care Skills

    The Performance-Based Assessment of Self-Care Skills (PASS) is a performance-based measure of activity performance. The PASS is validated for individual instrumental activities of daily living (IADLs) and therefore we will use the 14 physical emphasis IADLs, and the 4 cognitive emphasis IADLs.

    Time frame: Baseline, week 6-7, week 12-14

  2. Activities-Specific Balance Confidence Scale

    A standardized 16-item self-report measure of balance confidence, scores range from 0-100% with higher scores indicating greater confidence in balance when performing various functional activities.

    Time frame: Baseline, week 6-7, week 12-14

  3. Acceptability of Intervention Measure

    The Acceptability of Intervention Measure is a self-report measure used for intervention feedback. The assessment is 4 questions in total scored 4-20 with greater scores indicating greater acceptability.

    Time frame: week 12-14

  4. Intervention Appropriateness Measure

    The Intervention Appropriateness Measure is a self-report measure used for intervention feedback. The assessment is 4 questions in total scored 4-20 with greater scores indicating greater appropriateness.

    Time frame: week 12-14

  5. Feasibility of Intervention Measure

    The Feasibility of Intervention Measure is a self-report measure used for intervention feedback. The assessment is 4 questions in total scored 4-20 with greater scores indicating greater feasibility.

    Time frame: week 12-14

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — At the study completion, de-identified (i.e., not including name, or any identifying information) demographic data, health information data, self-reported falls data, and performance-based assessment data will be preserved to enable sharing on a repository for transparency and per NIH sharing agreements.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Reviewed by NACDA after study completion, data de-identification, and posting. Then NACDA maintains archives permanently.

Access criteria: NACDA's curation staff performs a reidentification risk and harm risk review of all data to ensure confidentiality is protected in released datasets. Data cleared for public access have minimal reidentification and harm risk, and therefore, no restrictions on access.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Aug 2028, 20 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2026
First posted
Nov 12, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
Aug 30, 2028
CompletionEst.
Aug 30, 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07931469
Responsible party
Sponsor
First posted
Nov 12, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Aug 30, 2028 (estimated)
Completion
Aug 30, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Laura A Swink, PhD
Contact
laura.swink@colostate.edu
9704917915

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion